Seeking Alpha

More on Covance (CVD): Q1 beats on all counts as total sales rose 9.3% Y/Y. Net profit jumped...

More on Covance (CVD): Q1 beats on all counts as total sales rose 9.3% Y/Y. Net profit jumped 35% on solid sales growth in its late-stage development business - which saw revenue grow by 17% - led by strength in its central laboratories and clinical development units. For the year, the company ups its EPS forecast to between $3 to $3.20 on revenue growth in the high-single digits. It previously had estimated earnings of around $2.85 to $3.15 and revenue growth in the mid-to-high single digits.

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs